Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal transducer and activator of transcription 2 (STAT2) is a transcription factor encoded by the STAT2 gene, critical for mediating cellular responses to Type I and Type III interferons (IFNs)[1][3]. In response to cytokine or growth factor signaling, STAT2 is phosphorylated by receptor-associated kinases (notably JAK1 and TYK2), forms a heterodimer with STAT1, and complexes with IRF9 to create the interferon-stimulated gene factor 3 (ISGF3) complex. This complex translocates to the nucleus to activate transcription of interferon-stimulated genes, which are essential for establishing an antiviral state and regulating immune responses[1][3][7]. Unlike other STAT proteins, STAT2 lacks DNA-binding capacity as a homodimer and functions primarily via its role in ISGF3. Mutations or deficiencies in STAT2 result in severe susceptibilities to viral infections and may be linked to rare forms of immunodeficiency[1]. Beyond classical interferon signaling, STAT2 also modulates the function of other STATs, acting as a negative regulator of STAT1 in certain cytokine pathways[7]. STAT2 interacts with several proteins including CREB-binding protein, IFNAR1, IFNAR2, IRF9, MED14, SMARCA4, and STAT1[1], and is essential for the transcriptional activation of antiviral and immunoregulatory genes.
For inhibitors of the JAK/STAT pathway, the mechanism involves inhibition of tyrosine phosphorylation and activation, thereby blocking STAT2-dependent transcriptional programs[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal transducer and activator of transcription 2 (STAT2).